Live Breaking News & Updates on Iopharmaceutical

Stay informed with the latest breaking news from Iopharmaceutical on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Iopharmaceutical and stay connected to the pulse of your community

One-third of HHS appointees hop to industry jobs, raising conflict-of-interest concerns

Study reveals that 1/3 of HHS appointees between 2004 and 2020 left for jobs in the industry, raising concerns about potential conflict-of-interest risks. Autho

Genevieve-kanter , Health-affairs , Price-school-of-public , Harvard-university , Public-policy , Daniel-carpenter , Healthcare-regulation , Evolving-door , Onflict-of-interest , Hs , Iopharmaceutical , Evice-manufacturers

Elevate Biopharmaceutical Processing with CAPP Media Bottles : Get Quote, RFQ, Price or Buy

Discover CAPP's Media Bottles, the perfect solution for all biopharmaceutical processing and lab storage needs.

Bottles , Iopharmaceutical ,

US Capital Global Engaged by PlantForm Corporation as

US Capital Global has been engaged by Canadian biotech firm developing plant-made pharmaceuticals for exposure to chemical weapons, such as sarin gas and...

Dubai , Dubayy , United-arab-emirates , United-states , Philadelphia , Pennsylvania , Brazil , Australia , London , City-of , United-kingdom , Dallas

Women in Science: Kerry's Barbara Morgan on her 'elaborate' science fair projects and innate curiosity

Barbara Morgan is vice president and portfolio executive at public food company Kerry Group, heading up their global pharma and biopharma business.

Morgan , Organic-chemistry , Biopharma-culture , Ipelines , Merging-markets , Ell-amp-gene-therapies , Erry-group , Iopharmaceutical , Iologics , Ell-and-gene-therapy ,

The crossover potential of nursing and pharmacy work

It isn't common for a nurse to become a pharmacist, but a few programs have sprung up to encourage this transition as pharmacists become more patient-facing healthcare workers.

Lebanon , Cecilia-costello , Joe-burczynski , Gina-batterman , Accreditation-council-for-medical-affairs , N-dartmouth-health , Linkedin , Lake-erie-college-of-osteopathic-medicine , Uw-health , Bureau-of-labor-statistics , Dartmouth-health , Lake-erie-college

Klietmann: Expanding drug price controls will hurt innovation

Enacting more price controls -- before the first ones have even taken effect -- would do far more harm than good to American patients and the future of medicine.

Australia , Boston , Massachusetts , United-states , Canada , Bay-state , Japan , South-korea , Cambridge , Cambridgeshire , United-kingdom , Washington

South SF biopharma company fined for hazmat violations | Bay Area News

EPA inspectors allegedly found several violations at the company's facility

Martha-guzman , Genentech , Us-environmental-protection-agency , South-san-francisco , Protection-agency , Pacific-southwest-regional-administrator , Outh-san-francisco , Pa , S-environmental-protection-agency , Iopharmaceutical ,

New treatment approach shows promise in reversing hormone resistance in breast cancer

A collaborative study between LSU Health New Orleans School of Medicine, the University of Rochester and Cellestia Biotech AG, a biopharmaceutical company headquartered in Basel, Switzerland, provides compelling evidence that combining an investigational oral drug with standard-of-care medications reverts hormone resistance and increases Rx effectiveness in experimental models of estrogen-receptor positive (ER+) and triple-negative breast cancers (TNBC), respectively.

Switzerland , United-states , American , Jovanny-zabaleta , Giulia-monticone , Fokhrul-hossain , Luis-del-valle , Samarpan-majumder , Dorota-wyczechowska , Danielle-ellis , Lucio-miele , University-of-rochester

Qiagen expands range of digital PCR kits and services for biopharma industry

Qiagen has announced the expansion of its digital PCR (dPCR) offering for the development of cell and gene therapies in the biopharma industry.

David-dobnik , Michael-scheffler , Niba-labs , Vector-lysis-kit , Good-manufacturing-practice , Markets-amp-regulations , Merging-markets , Iagen , Iopharmaceutical , Ell-and-gene-therapy , Anufacturing

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that The Lancet Infectious Diseases published results from the company's OVX836-003 study under the title, "Immunogenicity, safety and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: randomized, double-blind placebo-controlled, Phase 2a trial."

Lancet-infectious-diseases , Infectious-diseases , Nfluenza , Accine , Ntigen , Iopharmaceutical , D4 , Ell , Fficacy , Anoparticle , Lacebo